ResearchMoz

Global Proton Therapy Market: Trends & Opportunities (2013-2018)

Daedal Research
Published Date » 2014-02-01
No. Of Pages » 68

Executive Summary

Proton therapy or proton beam therapy is a highly precise method of radiotherapy. The treatment is suitable for all patients regardless of age and as proton-therapy technology is continuously advancing, features such as rotational gantries, higher energies and larger fields have expanded the treatment's application to potentially any site in the body. IBA is the world leader and market pioneer of proton therapy.

Globally the penetration of proton therapy centers is highest in North America, mainly in the US, followed by Europe and Asia. The US retains the highest number of proton therapy centers and many are in development phase or under construction. Proton therapy technology has also made inroads in different countries as various governments are showing interest in this advanced technology. Proton therapy is still developing in Europe, mainly because of low awareness of this therapy and also because it is comparatively expensive. But as the therapy is getting acceptability because of its effectiveness, and this technology holds immense potential as evident in the growing number of proton centers across the world.

One of the chief arguments against the procedure of proton therapy is its massive cost as it is hugely expensive to set-up and deliver a proton beam therapy center. Further, new technology such as pencil beam scanning is coming up which has the ability to treat the most complex of tumors, while leaving healthy tissue and critical structures untouched. This technology is used with proton therapy and many new proton centers are adapting this technology.

Scope of the Report

The report titled Global Proton Therapy Market: Trends and Opportunities (2013-2018) analyzes the potential opportunities and significant trends in the global proton therapy market. The report also provides detailed analysis of the global proton therapy market, with data of regional markets such as North America, Europe and Asia. The report also profiles and analyzes the business strategies of the leading companies operating in the segment.

Geographical Coverage

  • Global
  • North America
  • Europe
  • Asia

Company Profiles

  • IBA Proton Therapy Inc.
  • Hitach 
  • Varian Medical System
  • Mitsubishi Energy and Electrical Corporation
Table of Content

1. Executive Summary

2. Introduction
2.1 Proton Therapy
2.2 Science of Proton Therapy
2.2 Application of Proton Therapy
2.3 Comparison of Proton Therapy with Other Treatments
2.3.1 Proton Therapy and X-ray Radiation
2.3.2 Proton Therapy and Surgery
2.4 Treatment by Proton Therapy
2.4.1 Prostate Cancer
2.4.2 Brain Cancer
2.4.3 Eye Cancer
2.4.4 Head and Neck Cancer
2.4.5 Lung Cancer
2.4.6 Bone Cancer
2.4.7 Hodgkin Lymphoma
2.4.8 Pancreatic Cancer
2.4.9 Pediatric Cancer
2.4.10 Sarcoma
2.4.11 Breast Cancer
2.5 Different Devices Used in Proton Therapy

3. Market Size of Proton Therapy Industry: Analysis and Forecast
3.1 Count of Proton Therapy Treatment Rooms Worldwide
3.2 Global Market size of Proton Therapy Device Industry
3.3 Growth in Proton Therapy Treating Rooms
3.4 Oncology Therapies Cost Comparison

4. North American Proton Therapy Market
4.1 Treatment Centers in Operation
4.2 Upcoming Treatment Centers

5. European Proton Therapy Market
5.1 Treatment Centers in Operation
5.2 Upcoming Treatment Centers

6. Asian Proton Therapy Market
6.1 Treatment Centers in Operation
6.2 Upcoming Treatment Centers

7. Market Dynamics
7.1 Growth Drivers
7.1.1 Increasing Population
7.1.2 Global GDP
7.1.3 Increasing Count of Cancer Patients
7.2 Challenges
7.2.1 Setup Costs
7.2.2 Range Uncertainty
7.3 Market Trends
7.3.1 New Technology
7.3.2 Pencil Beam Scanning

8. Competitive Landscape

9. Company Profile
9.1 IBA Proton Therapy Inc
9.1.1 Business Overview
9.1.2 Financial Overview
9.1.3 Business Strategy
9.2 Hitachi
9.2.1 Business Overview
9.2.2 Financial Overview
9.2.3 Business Strategy
9.3 Varian Medical System
9.3.1 Business Overview
9.3.2 Financial Overview
9.3.3 Business Strategy
9.4 Mitsubishi Energy and Electrical Corporation
9.4.1 Business Overview
9.4.2 Financial Overview
9.4.3 Business Strategy

List of Tables


Table 1: Treatment by Proton Therapy
Table 2: Estimate of Yearly Risk of Developing Secondary Cancer in Children after Receiving Proton, X-ray and IMRT for Different Types of Tumor
Table 3: Percentage of Patients Having Complications after Undergoing Radiotherapy for Left and Right sided Breast Cancer
Table 4: Patients Mix Treated With Proton Therapy
Table 5: Oncology Therapies Cost Comparison
Table 6: List of Operating Proton Therapy Centers in North America
Table 7: List of Operating Proton Therapy Centers in Europe
Table 8: List of Upcoming Proton Therapy Centers in Europe
Table 9: List of Operating Proton Therapy Centers in Asia
Table 10: List of Upcoming Proton Therapy Centers in Asia
Table 11: Comparison of Different Companies on the Basis of Experience and Technology

List of Figures


Figure 1: Science of Proton Therapy
Figure 2: Difference in Working of Proton Therapy and X-ray Radiation
Figure 3: Percentage of Prostate Cancer Patients Experiencing Side Effects after Proton Therapy and X-ray Radiation
Figure 4: Percentage of Prostate Cancer Patients whose PSA level after Proton Therapy and X-ray Radiation
Figure 5: Percentage of patients Experiencing Esophagus Inflammation after Proton and Photon Therapy
Figure 6: Share of People Cured by Chemotherapy in Hodgkin Lymphoma Cancer
Figure 7: Accelerator (Synchrotron)
Figure 8: Number of Proton Therapy Treating Rooms Worldwide: 2008 to 2012
Figure 9: Number of Proton Therapy Treating Rooms Worldwide Forecast: 2013 to 2018
Figure 10: Global Market Size of Proton Therapy Device Industry: 2008 to 2012 (US$ Million)
Figure 11: Global Market Size of Proton Therapy Device Industry Forecast: 2013 to 2018 (US$ Million)
Figure 12: Growth in Proton Therapy Treating Rooms: 2008 to 2012
Figure 13: Population Growth by Region: 1990-2010
Figure 14: Global GDP: 2005 to 2012 (US$ Trillion)
Figure 15: Percentage of Deaths from Cancer by Region
Figure 16: Pencil Beam Scanning
Figure 17: Market Share of Rooms in Operation by Company (2012)
Figure 18: Market Share of Rooms Sold by Company (2012)
Figure 19: Number of Proton Therapy Rooms Ordered and In Operation by Companies
Figure 20: IBA Proton Therapy Inc. Revenue: 2008 to 2012 (US$ Million)
Figure 21: IBAs Revenue Share (2012)
Figure 22: Hitachis Revenue: FY2008 to FY2012 (US$ Billion)
Figure 23: Varians Revenue: FY2008 to FY2012 (US$ Billion)
Figure 24: Mitsubishi Energy and Electrical Corporation Revenue: FY2008 to FY2012 (US$ Billion)

Upcoming Reports:

Frozen Processed Food Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts, 2012 - 2018
By - Transparency Market Research
Despite rising costs of raw materials and increasing unit prices of frozen processed food, the frozen processed food market is growing rapidly. New product launches, re-positioning of products, and perception of products amongst end users are some of the major reasons for the continuous growth of this market. Frozen processed food is easier to prepare than fresh food and can be stored in freezers for extended durations of time. Also, these foods maintain the same nutritional values as fresh food, which makes them more preferred than fresh food. The frozen processed food market is...
Autologous Cell Therapy Market - Global Forecast, Market Share, Size, Growth and Industry Analysis, 2011-2018
By - Transparency Market Research
Autologous cell therapy is a therapeutic procedure which uses the cells of an individual, which are well-bred and nurtured outside the body and then reintroduced at the site of the disease of the individual. Autologous cell therapy is a new breakthrough in the field of medical history. Autologous cell therapy (ACT) is one of the most rapidly evolving fields due to the revolution in the bioengineering sector since the last few decades.  Previously diseases like Alzheimer’s, Parkinson's were thought to be incurable; however the invention of Autologous cell therapy...
Smart And Interactive Textiles Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
Smart textiles are fabrics that have electronic and digital components embedded in them. There is a seamless integration of textiles with electronic elements such as sensors, actuators and micro-controllers. Smart textiles can be classified into two categories viz., passive smart textiles and active smart textiles. Passive smart textiles include textiles which provide additional features irrespective of the change in environment. Active smart textiles are textiles which adapt functionality to environment automatically. Smart textiles can be used in a large variety of applications such as...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

India is Facing a Cancer Crisis
Apr 15, 2014  
India is currently facing a cancer crisis – reports a recent research carried out at the King’s college London, in collaboration with the Tata Memorial Cancer Centre, Mumbai.  The reasons estimated for this crisis comprise of increasing rates of smoking, unequal access to proper treatment and belated diagnosis.  Every year, India witnesses around one...
Microparticle Tags to Check Counterfeit Goods Invented
Apr 14, 2014  
Researchers from the Massachusetts Institute of Technology have invented a new set of microparticles that can easily be read by smartphones and establish the authenticity of currency, electronic items and luxury goods.  This strategy is among those countless measures taken by big brands and companies to label their legitimate products in order to stop illegal copies of the...
USFDA Approves Lupins Generic Diabetic Drug
Apr 10, 2014  
The United States Food and Drugs Administration (USFDA) has finally approved Lupin Pharmaceuticals Inc (LPI), the American subsidiary of Indian drug manufacturers Lupin Ltd, to sell Pioglitazone Tablets in the U.S market. The approval has been granted first for fiscal 2015.  Pioglitazone is a generic medicine used for managing diabetes and is a version of Actos tablets...
Infrared Sensors can Soon Be Used to Develop Night-Vision Lenses - A New Discovery Confirms
Apr 8, 2014  
People who fear the dark may soon have a reason to rejoice – an infrared sensor that can eventually be used for mechanizing night-vision lenses has been developed. This effectively means that one can also see through dark with the help of these lenses.  This technology seems possible all due to graphene, a layer of tightly packed carbon atoms that has allowed the creation of...
Ontarios thanks Sustainable Development Technology Canada for Clean Tech Ecosystem Movements
Apr 8, 2014  
Sustainable Development Technology Canada has leveraged an extra $2.2 billion in funding from project partners that also includes global clean technology companies.  Sustainable Development Technology Canada (SDTC) is energizing and evolving the development and demonstration of a clean technology ecosystem. They are the vital contributors to the prominent concentration of clean...